IRIS
SAMBATARO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.963
AS - Asia 1.034
EU - Europa 452
SA - Sud America 220
AF - Africa 17
OC - Oceania 1
Totale 3.687
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.918
SG - Singapore 347
IT - Italia 215
HK - Hong Kong 195
CN - Cina 183
BR - Brasile 163
BD - Bangladesh 111
VN - Vietnam 111
DE - Germania 63
FR - Francia 53
AR - Argentina 26
CA - Canada 26
IE - Irlanda 24
GB - Regno Unito 20
IN - India 19
AT - Austria 18
ID - Indonesia 16
NL - Olanda 15
EC - Ecuador 12
FI - Finlandia 10
MX - Messico 10
TR - Turchia 10
IQ - Iraq 8
PL - Polonia 7
CO - Colombia 6
ES - Italia 6
RU - Federazione Russa 6
ZA - Sudafrica 6
CL - Cile 5
JP - Giappone 5
MA - Marocco 5
AZ - Azerbaigian 4
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
CR - Costa Rica 2
IL - Israele 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
SE - Svezia 2
UA - Ucraina 2
VE - Venezuela 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
Totale 3.687
Salva come PNG Salva come JPEG
Città #
Dallas 1.214
Hong Kong 194
San Jose 169
Singapore 149
Ashburn 107
Ho Chi Minh City 54
Chicago 44
The Dalles 44
Beijing 38
New York 34
Milan 29
Dublin 24
Santa Clara 21
Naples 18
São Paulo 16
Hanoi 13
Catania 12
Hillsboro 11
Los Angeles 11
Montreal 11
Rome 11
Frankfurt am Main 10
Buffalo 9
Helsinki 8
Istanbul 8
Orem 8
Palermo 8
Rio de Janeiro 8
Amsterdam 7
Boardman 7
Munich 7
Turin 7
Chennai 6
Council Bluffs 6
Düsseldorf 6
Mexico City 6
Quito 6
Biên Hòa 5
Boston 5
Brasília 5
Manchester 5
Misilmeri 5
Nuremberg 5
Porto Alegre 5
Vienna 5
Warsaw 5
Assago 4
Baghdad 4
Baku 4
Bologna 4
Brooklyn 4
Curitiba 4
Dhaka 4
Genoa 4
Guayaquil 4
Haiphong 4
Limburg an der Lahn 4
Seattle 4
Triggiano 4
Atlanta 3
Bari 3
Campinas 3
Casoria 3
Durban 3
Ealing 3
Guarulhos 3
Joinville 3
London 3
Messina 3
Mumbai 3
Resistencia 3
Ribeirão Preto 3
San Francisco 3
Tashkent 3
Varallo Pombia 3
Abbotsford 2
Alessandria 2
Avellino 2
Bandung 2
Belo Horizonte 2
Bogotá 2
Buenos Aires 2
Buritama 2
Cagliari 2
Can Tho 2
Chittagong 2
Corato 2
Cypress 2
Da Nang 2
Duque de Caxias 2
Florence 2
Fortaleza 2
General Roca 2
Hortolândia 2
Hải Dương 2
Ijuí 2
Independencia 2
Isidro Casanova 2
Jacksonville 2
Johannesburg 2
Totale 2.536
Salva come PNG Salva come JPEG
Nome #
Opsoclonus-myoclonus Syndrome in a Female Breast Cancer Patient: A Case Report and Literature Review 281
Neurocrine tumors of the lung [I TUMORI NEUROENDOCRINI DEL POLMONE] 256
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 234
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: A phase II study 187
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 90
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 87
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care 83
Brain Metastasis in Endometrial Cancer: A Systematic Review 80
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic Strategy 78
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 78
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 78
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial 74
Nonpegylated liposome-encapsulated doxorubicin (NPLED) and cyclophosphamide in the treatment of platinum-resistant ovarian cancer: Final results of a phase II study 68
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 67
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 66
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study 64
Risk-reducing mastectomy in healthy women with BRCA mutation: a narrative review 64
Prognostic Factors for Adrenocortical Carcinoma Outcomes 62
Livelli sierici del recettore solubile dell’interleuchina 2 in pazienti con carcinoma del polmone in stadio III o IV in trattamento antiblastico o radiante Livelli sierici del recettore solubile dell’interleuchina 2 in pazienti con carcinoma del polmone in stadio III o IV in trattamento antiblastico o radiante 61
Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients 59
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 59
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 58
[Second-line chemotherapy and new drugs for ovarian carcinoma] 57
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 56
Chemotherapy extravasation: diagnosis, prevention and management 54
IL-6-174 G>C and MMP-9-1562 C>T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients 54
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 54
A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features 53
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 51
LONG-TERM CANCER SURVIVORS: CONCERNS AND UPDATES 50
Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network 49
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 47
Effectiveness of low molecular weight heparin (LMWH) in cancer-related disseminated intravascular coagulation (DIC). A case report 45
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial 44
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast Cancer 43
Exploratory Analysis of Dunning–Kruger Effect Among Oncologists Managing Prostatic Adenocarcinoma Candidates for Radionuclide Therapy 42
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 41
Bronchial carcinoid associated with Cushing's syndrome 39
Bronchial carcinoid associated to Cushing syndrome|IL CARCINOIDE BRONCHIALE ASSOCIATO A SINDROME DI CUSHING 36
The immune system response during development and progression of carcinogen-induced rat mammary tumors: prevention of tumor growth and restoration of immune system responsiveness by thymopentin 35
The pathology of medullary carcinoma of the thyroid: Review of the literature and personal experience on 62 cases 29
Il sistema immunitario durante la progressione tumorale: approccio sperimentale e clinico 25
Il deficit cognitivo nei pazienti oncologici in trattamento antiblastico. 23
Study on the perception of memory and concentration deficit of patients undergoing antiblastic therapy. 22
Activity and safety of CPBev regimen (Cis-platinum, Pemetrexed and Bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: final results of a phase II study. 22
Implementation of a clinical governance model (UFA-ONCO-HEMA model) for anticancer drugs delivering and its adoption by a Regional Health Department 21
Oxaliplatin (L-OHP), folinic and fluorouracil (5FU) for advanced breast cancer (BC) patients (pts) refractary to anthracyclines (ant) and taxanes (tax). 20
Escalating Doses of gemcitabine in combination with cisplatin in advanced urothelial carcinoma: a dose finding study. 20
ATHENA (GOG-3020/ENGOT-ov45): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study of the Poly (ADP-Ribose) Polymerase (PARP) Inhibitor Rucaparib + the PD-1 Inhibitor Nivolumab Following Frontline Platinum-Based Chemotherapy in Ovarian Cancer 19
Follow up of colorectal cancer 19
Pegylated liposomial doxorubicin with escalating dose vinorelbina in metastatic breast carcinoma: a dose finding study. 19
Melanoma Sliding Doors 2022 Management and targeted treatment for melanoma BRAF+ patients 18
Utilità di un follow up accurato nel trattamento delle metastasi polmonari ed epatiche da carcinoma colo-rettale: descrizione di due casi clinici. 17
Melanoma Setting Next Horizon 2023. Mnagement and targeted treatment for melanoma BRAF+ Patients. 17
Assessing awareness and knowledge of Human Papilloma virus infection in high school studente 16
Il trattamento del carcinoma gastrico localmente avanzato e metastatico in regime di day hospital: possibilità di applicazione dell’infusione continua (ECF) 16
Tossicità dell’associazione RT-CT nel carcinoma del retto: valutazione della fattibilità in rapporto al regime citostatico adottato 16
THE ONCOLOGICAL SITUATION IN SICILY: PUBLIC AND PRIVARE STRUCTURES 16
Toxicity From Monoimmunotherapy In Patients Aged =80 Years: Our Experience 16
PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG 15
Adjuvant treatment of colo-rectal cancer with combined chemotherapy and radiation therapy 15
Doppia modulazione del 5 FU con Leucovorin ed Interferon * nel carcinoma colorettale in stadio avanzato. Risultati di uno studio clinico. 15
Second- and third-line chemotherapy in advanced gastric cancer: a real-life clinical picture. 15
Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study. 15
Retrospective study about treatment protocol of an advanced colorectal carcinoma by 5fluouracil double modulation by leucovorin and interferon. 14
Nutritional Status, Inflammatory Parameters and Cancer 14
Effetto dell’interleuchina 2 sulla mucosite indotta da trattamento citostatico con 5 fluorouracile ad alte dosi in infusione continua e acido folinico in pazienti con adenocarcinoma del colon retto in stadio avanzato. 14
Trombosi e Cancro 14
Preliminary study on financial toxicity perception among cancer patients: The financial toxicity questionnaire 16 13
Importanza di una adeguata terapia nutrizionale di supporto nel paziente neoplastico in fase avanzata: l’esperienza di un day hospital oncologico. 13
A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival 13
MITO-11 - A randomized multicenter phase II trial testing the addition of pazopanib to weekly paclitaxel in platinum resistant or refractory advanced ovarian cancer (AOC) 13
Drug-drug interaction between antineoplastic drug based protocols and general medications: a novel approach in the clinical practice 13
The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience 12
Escalating Doses of Paclitaxel in combination with Epirubicin and Cisplatin in Advanced Ovarian Epithelial Carcinoma: A Dose Finding Study. 12
Chemotherapy for transitional cell carcinoma (TCC) patients (pts) unsuitable to cisplatinum: a phase II study of gemcitabine (G) and vinorelbine (V) combination. 12
Tumor markers in the diagnosis, prognosis, and follow-up of colorectal cancer: CEA, CA 19-9 and TPA 12
5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plus Bevacizumab in patients with metastatic colo-rectal cancer (MCRC): a multicentric phase II trial 12
The Astrocyte as Target and Source of Mediators of Immune and Neuroendocrine Systems The Astrocyte as Target and Source of Mediators of Immune and Neuroendocrine Systems 12
Phase II study of irinotecan and fluorouracil/leucovorin (FOLFIRI) in patients with primary advanced gastric cancer. Preliminary results 11
Terapia adiuvante e qualità di vita: tossicità del trattamento con folati e 5-FU a scopo precauzionale e sue implicazioni cliniche 11
Neoadjuvant chemotherapy followed by surgery in patients with squamous cell cervical carcinoma 11
Metronomic shedule of Capecitabine in poor performance status Patients (PTS) with pretreated solid tumors 11
Gemcitabine (G) as a six-hour infusion in patients (pts) with metastatic, largely treated, solid tumours. 11
Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire. 10
Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her 2 positive metastatic breast cancer (mBC) 10
Tromboembolismo in oncologia medica 10
Neuroimmunomodulation in Neoplasia: Role of Cytokines and Thimic Hormones 10
Descrizione e valutazione di alcuni casi di metastasi epatiche da carcinomi del grosso intestino trattate con terapia citostatica e successiva resezione 10
Determinazione della Triiodiotironina con tecniche immunochimiche non radioisotopiche Determination of Triiodiothyronine by non radioisotopic techniques 9
Beyond BRCA: preliminary results of a study for the implementation of hereditary cancer diagnoses. 8
Observational Study on the Effectiveness of L-Arginine Plus Vitamin C in the Management of Cancer-related Fatigue 6
Valutazione di CEA, TPA E CA 15.3 nel follow-up del carcinoma della mammella e nel monitoraggio della risposta alla terapia nella fase avanzata. 6
Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review 4
Magnesium and Cancer Immunotherapy: A Narrative Practical Review 3
Adjuvant endocrine therapy in estrogen-low breast cancer in the era of CDKI: are we at another uncertain crossroads? 3
From Feasibility to Individualization: Surgery for Breast Cancer Liver and Lung Metastases 2
Scientific Meetings in Medical Oncology: Are We Facing a Time- and Resource-Consuming Plethora? 2
Totale 3.871
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.503
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20245 0 0 0 0 0 0 0 0 0 0 0 5
2024/2025610 12 5 9 2 18 96 68 44 69 121 84 82
2025/20263.256 103 282 1.122 256 230 221 124 253 195 170 200 100
Totale 3.871